Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
LEO Pharma acquires Replay for $50m
LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.
Read more
LEO Pharma acquires Replay for $50m
LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.
£450m invested in UK by AZ and Boehringer
In good news for UK life sciences investment, two companies have made pledges to build new facilities.
Boehringer drug hits 16.6% weight loss in phase 3
The therapy survodutide works by reducing appetite while also targeting metabolism in the liver.
EMJ Podcast shortlisted for 2026 PPA Awards
The EMJ Podcast is a finalist for Audio Content of the Year at the 2026 PPA Awards, shortlisted from more than 260 entries reviewed by a panel of experts.
EMJ shortlisted for The Drum Awards for Marketing 2026
The European Medical Journal has been shortlisted for The Drum Awards for Marketing 2026, for its interactive digital tool combatting COPD diagnostic delays.
WHO backs first malaria treatment for newborns
Until now, there had been no approved malaria treatment for infants weighing less than 4.5kg.
Oral semaglutide shows promise in paediatric type 2 diabetes
A phase 3 trial has shown efficacy in type 2 diabetes for adolescents, positioning it as a potential first oral solution for this population.
Moderna initiates phase 3 bird flu vaccine trial
A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated.
Loading posts...
1
2
3
…
49
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View